AbbVie shares jump as results beat expectations despite blockbuster Humira’s declining sales By: MarketWatch July 27, 2023 at 11:15 AM EDT Newer immunology drugs Skyrizi and Rinvoq boost sales in second quarter. Read More >> Related Stocks: AbbVie Novo Nordisk A/S ADR